IDXX logo

IDEXX Laboratories (IDXX)

Profile

Full Name

IDEXX Laboratories, Inc.

Ticker Symbol

IDXX

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

June 21, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.idexx.com

Employees

11000

Key Details

Price

$390.94(+2.39%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.90B(+6.46% YoY)

Annual EPS

$10.67(+6.06% YoY)

PE ratio

36.64

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$390.94
IDXX price is $390.94

30-Day Relative Volume

1.47
IDXX 30-day relative volume is 1.47

Price Performance

Price Most recent change

+2.39%
IDXX price was up +2.39% on Apr 11, 2025

Price YTD change

-5.44%
IDXX price is down -5.44% since January 1st

Price 1-year change

-22.29%
IDXX price is down -22.29% year-on-year

Price 3-year change

-24.01%
IDXX price is down -24.01% over the past 3 years

Price Range

Price All-time high

$706.95
IDXX price is currently -44.70% below its historical high of $706.95

Price 3-year low

$317.06
IDXX price is currently +23.30% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$31.79B
IDXX market capitalization is $31.79 billion

Market cap 3-year change

-26.57%
IDXX market capitalization is down -26.57% over the past 3 years

Market cap All-time high

$60.04B
IDXX market capitalization is currently -47.05% below its historical high of $60.04 billion

Market cap sector rank

96.88%
IDXX market capitalization is higher than 96.88% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.86%
IDXX shares outstanding is down -1.86% year-on-year

Shares Outstanding 3-Year Change

-3.37%
IDXX shares outstanding is down -3.37% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
IDXX beta is 0.86

200-day SMA

$451.23
IDXX price is currently -13.36% below its 200-day simple moving average

50-day SMA

$431.10
IDXX price is currently -9.32% below its 50-day simple moving average

RSI

42.60
IDXX 14-day relative strength index is 42.60

Volume

1.47
IDXX 30-day relative volume is 1.47

ATR

$17.20
IDXX average true range is $17.20

10-day Historical Volatility

72.72%
IDXX 10-day historical volatility is 72.72%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.90B
IDXX annual revenue is $3.90 billion

Revenue Analysts estimate

$4.12B
IDXX annual revenue is currently -5.33% lower than the consensus analysts' forecast

Revenue 1-year change

+6.46%
IDXX annual revenue is up +6.46% year-on-year

Revenue Sector rank

90.37%
IDXX annual revenue is higher than 90.37% of companies in Healthcare sector

EPS

EPS

$10.67
IDXX annual earnings per share is $10.67

EPS Analysts estimate

$11.99
IDXX annual earnings per share is currently -11.04% lower than the consensus analysts' forecast

EPS 1-year change

+6.06%
IDXX annual earnings per share is up +6.06% year-on-year

EPS Sector rank

98.1%
IDXX annual earnings per share is higher than 98.1% of companies in Healthcare sector

Profit

Gross profit

$2.38B
IDXX annual gross profit is $2.38 billion

Gross margin

61.04%
IDXX annual gross profit margin is 61.04%

Operating profit

$1.13B
IDXX annual operating income is $1.13 billion

Operating margin

28.95%
IDXX annual operating profit margin is 28.95%

Net income

$887.87M
IDXX annual net profit is $887.87 million

Net margin

22.78%
IDXX annual net profit margin is 22.78%

Expenses

Total expenses

$2.77B
IDXX annual total expenses is $2.77 billion

Operating expenses

$1.25B
IDXX annual total operating expenses is $1.25 billion

Cost of goods sold

$1.52B
IDXX annual cost of goods sold is $1.52 billion

Selling, general & administrative expenses

$1.03B
IDXX annual SGA is $1.03 billion

Depreciation and amortization

$129.94M
IDXX annual depreciation & amortization is $129.94 million

Interest expense

$31.20M
IDXX annual interest expense is $31.20 million

Income tax

$221.96M
IDXX annual income tax is $221.96 million

EBIT & EBITDA

EBIT

$1.13B
IDXX annual earnings before interest & taxes is $1.13 billion

EBITDA

$1.13B
IDXX annual EBITDA is $1.13 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.29B
IDXX annual total assets is $3.29 billion

Non current assets

$1.89B
IDXX annual long term assets is $1.89 billion

Current assets

$1.40B
IDXX annual total current assets is $1.40 billion

Cash and cash equivalents

$288.27M
IDXX annual cash & cash equivalents is $288.27 million

Accounts receivable

$473.57M
IDXX annual accounts receivable is $473.57 million

Inventory

$381.88M
IDXX annual inventory is $381.88 million

Liabilities

Total liabilities

$1.70B
IDXX annual total liabilities is $1.70 billion

Long term liabilities

$630.21M
IDXX annual total long term liabilities is $630.21 million

Current liabilities

$1.07B
IDXX annual total current liabilities is $1.07 billion

Accounts payable

$114.21M
IDXX annual accounts payable is $114.21 million

Debt

Total debt

$986.95M
IDXX annual total debt is $986.95 million

Total debt 1-year change

-7.53%
IDXX annual total debt is down -7.53% year-on-year

Long term debt

$547.62M
IDXX annual long term debt is $547.62 million

Short term debt

$439.33M
IDXX annual short term debt is $439.33 million

Equity & Capital

Shareholders equity

$1.60B
IDXX annual stockholders equity is $1.60 billion

Book value

$1.60B
IDXX annual book value is $1.60 billion

Retained earnings

$5.33B
IDXX annual retained earnings is $5.33 billion

Working capital

$331.98M
IDXX annual working capital is $331.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$929.00M
IDXX annual cash flow from operations is $929.00 million

Cash from operations 1-year change

+2.48%
IDXX annual cash flow from operations is up +2.48% year-on-year

Cash from investing

-$207.06M
IDXX annual cash flow from investing activities is -$207.06 million

Cash from investing 1-year change

-65.31%
IDXX annual cash flow from investing activities is down -65.31% year-on-year

Cash from financing

-$878.07M
IDXX annual cash flow from financing activities is -$878.07 million

Cash from financing 1-year change

-98.66%
IDXX annual cash flow from financing activities is down -98.66% year-on-year

CAPEX

CAPEX

$120.92M
IDXX annual capital expenditures is $120.92 million

CAPEX 1-year change

-9.51%
IDXX annual capital expenditures is down -9.51% year-on-year

Free Cash Flow

Free cash flow

$808.08M
IDXX annual free cash flow is $808.08 million

Free cash flow 1-year change

+4.55%
IDXX annual free cash flow is up +4.55% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.04%
IDXX annual gross profit margin is 61.04%

Operating margin

28.95%
IDXX annual operating profit margin is 28.95%

Net margin

22.78%
IDXX annual net profit margin is 22.78%

ROA & ROE

ROA

27.10%
IDXX annual return on assets is 27.10%

ROE

57.66%
IDXX annual return on equity is 57.66%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

36.64
IDXX price to earnings ratio is 36.64

PE ratio Sector rank

69.12%
IDXX price to earnings ratio is higher than 69.12% of companies in Healthcare sector

PB Ratio

PB ratio

19.93
IDXX price to book ratio is 19.93

PB ratio Sector rank

96.63%
IDXX price to book ratio is higher than 96.63% of companies in Healthcare sector

PS Ratio

PS ratio

8.16
IDXX price to sales ratio is 8.16

PS ratio Sector rank

76.15%
IDXX price to sales ratio is higher than 76.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$32.49B
IDXX enterprise value is $32.49 billion

Enterprise value Sector rank

96.62%
IDXX enterprise value is higher than 96.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

26.31
IDXX EV/EBITDA is 26.31

EV/EBITDA Sector rank

94.01%
IDXX EV/EBITDA is higher than 94.01% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.31
IDXX annual current ratio is 1.31

Quick ratio

0.95
IDXX annual quick ratio is 0.95

Leverage

Debt to equity

0.54
IDXX annual debt to equity ratio is 0.54

Interest coverage ratio

36.16
IDXX annual interest coverage ratio is 36.16

Risk & Stability

Piotroski F-Score

7
IDXX piotroski f-score is 7

Altman Z-Score

15.94
IDXX altman z-score is 15.94

Analyst ratings

Recent major analysts updates

Feb 10, 25 Piper Sandler
Neutral
Feb 4, 25 Barclays
Overweight
Feb 4, 25 B of A Securities
Neutral
Jan 29, 25 Morgan Stanley
Overweight
Dec 2, 24 Leerink Partners
Outperform
Nov 4, 24 Piper Sandler
Neutral
Nov 4, 24 Barclays
Overweight
Oct 11, 24 JP Morgan
Overweight
Oct 10, 24 Stifel
Hold
Aug 14, 24 Piper Sandler
Neutral

Institutional Ownership

Similar stocks

CAH logo
Cardinal Health (CAH)
CNC logo
Centene (CNC)
RMD logo
ResMed (RMD)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
A logo
Agilent Technologies (A)
GEHC logo
GE HealthCare Technologies (GEHC)
ARGX logo
argenx SE (ARGX)
VEEV logo
Veeva Systems (VEEV)
HUM logo
Humana (HUM)
  • What is the ticker symbol for IDEXX Laboratories?
  • Does IDEXX Laboratories pay dividends?
  • What sector is IDEXX Laboratories in?
  • What industry is IDEXX Laboratories in?
  • What country is IDEXX Laboratories based in?
  • When did IDEXX Laboratories go public?
  • Is IDEXX Laboratories in the S&P 500?
  • Is IDEXX Laboratories in the NASDAQ 100?
  • Is IDEXX Laboratories in the Dow Jones?
  • When was IDEXX Laboratories's last earnings report?
  • When does IDEXX Laboratories report earnings?
  • Should I buy IDEXX Laboratories stock now?

What is the ticker symbol for IDEXX Laboratories?

The ticker symbol for IDEXX Laboratories is NASDAQ:IDXX

Does IDEXX Laboratories pay dividends?

No, IDEXX Laboratories does not pay dividends

What sector is IDEXX Laboratories in?

IDEXX Laboratories is in the Healthcare sector

What industry is IDEXX Laboratories in?

IDEXX Laboratories is in the Diagnostics & Research industry

What country is IDEXX Laboratories based in?

IDEXX Laboratories is headquartered in United States

When did IDEXX Laboratories go public?

IDEXX Laboratories's initial public offering (IPO) was on June 21, 1991

Is IDEXX Laboratories in the S&P 500?

Yes, IDEXX Laboratories is included in the S&P 500 index

Is IDEXX Laboratories in the NASDAQ 100?

Yes, IDEXX Laboratories is included in the NASDAQ 100 index

Is IDEXX Laboratories in the Dow Jones?

No, IDEXX Laboratories is not included in the Dow Jones index

When was IDEXX Laboratories's last earnings report?

IDEXX Laboratories's most recent earnings report was on Feb 3, 2025

When does IDEXX Laboratories report earnings?

The next expected earnings date for IDEXX Laboratories is May 1, 2025

Should I buy IDEXX Laboratories stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page